COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 780: Articles 7791-7800  | Next

Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins
Chonira, V. K., Kwon, Y.-D., Gorman, J., Case, J. B., Ku, Z., Simeon, R., Casner, R. G., Harris, D. R., Olia, A. S., Stevens, T., Shapiro, L., Boyd, H., Tsybovsky, Y., Krammer, F., Diamond, M., Kwong, P. D., An, Z., Chen, Z.
10.1101/2022.05.30.493765 — Posted: 2022-05-31
SARS-CoV-2 Helicase might interfere with cellular nonsense-mediated RNA decay, insights from a bioinformatics study
Akbari, B., Ahmadi, E., Zamir, M. R., Shaker, M. S., Noorbakhsh, F.
10.1101/2022.05.30.494036 — Posted: 2022-05-31
HMGB1 correlates with severity and death of COVID-19 patients
Vicentino, A. R. R., Fraga Junior, V. d. S., Palazzo, M., Tasmo, N. R. A., Rodrigues, D. A. S., Barroso, S. P. C., Ferreira, S. N., Borges, A. C. N., Allonso, D., Fantappie, M. R., Scharfstein, J., Oliveira, A. C., Vianna-Jorge, R., Vale, A. M., Coutinho-Silva, R., Savio, L. E. B., Canetti, C., Benjamim, C. F.
10.1101/2022.05.26.22275611 — Posted: 2022-05-31
Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge
Sun, S., Li, E., Zhao, G., Tang, J., Zuo, Q., Cai, L., Xu, C., Sui, C., Ou, Y., Liu, C., Li, H., Ding, Y., Li, C., Lu, D., Zhang, W., Luo, P., Cheng, P., Gao, Y., Tu, C., Pitard, B., Rosenecker, J., Wang, B., Liu, Y., Zou, Q., Guan, S.
10.1101/2022.05.29.493866 — Posted: 2022-05-30
The U.S. academic job market survives the SARS-CoV-2 global pandemic
Kozik, A. J., Hagan, A., Jadavji, N. M., Smith, C. T., Haage, A.
10.1101/2022.05.27.493714 — Posted: 2022-05-30
Governance is key to controlling SARS-CoV-2's vaccine resistance
Okamoto, K. W., Chaves, L. F., Wallace, R., Wallace, R. G.
10.1101/2022.05.26.22275649 — Posted: 2022-05-30
Genome similarities between human-derived and mink-derived SARS-CoV-2 make mink a potential reservoir of the virus
Khalid, M., Al-ebini, Y.
10.1101/2022.05.29.493871 — Posted: 2022-05-30
The SARS-CoV-2 accessory factor ORF7a downregulates MHC class I surface expression
Zheng, S., de Buhr, H., Praest, P., Evers, A., Brak Boer, I., van Grinsven, M., Longo, Y., de Vries, L., Nijenhuis, W., Kapitein, L. C., Beekman, J. M., Nijhuis, M., Drexler, I., Wiertz, E. J., Lebbink, R. J.
10.1101/2022.05.29.493850 — Posted: 2022-05-30
Increased ambulance attendances related to suicide and self-injury in response to the pandemic
John, J., Synn, E. P., Winata, T., Eapen, V., Lin, P.-I.
10.1101/2022.05.29.22273082 — Posted: 2022-05-30
Incidence of Post-Covid Syndrome and Associated Symptoms in Outpatient Care in Bavaria, Germany
Donnachie, E., Hapfelmeier, A., Linde, K., Tauscher, M., Gerlach, R., Greissel, A., Schneider, A.
10.1101/2022.05.29.22275262 — Posted: 2022-05-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).